Prevalence of multidrug-resistant bacteria in community-acquired patients admitted to the intensive care unit of the Valença Teaching Hospital – RJ
DOI:
https://doi.org/10.24859/SaberDigital.2026v19n2.1918Keywords:
Multidrug Resistance, Intensive Care Units, Infection Control, Bacterial Colonization, Active SurveillanceAbstract
Introduction: The presence of multidrug-resistant (MDR) microrganisms in Intensive Care Units (ICUs) represents a growing challenge for public health, especially when identified in patients admitted without prior hospitalization. This study aimed to analyze the prevalence of multidrug-resistant bacterial colonization at the time of admission in patients at the ICU of Hospital Escola de Valença (RJ), between August 2022 and December 2023. Materials and Methods: This is an observational, prospective, and descriptive study based on the analysis of laboratory data from nasal and rectal swabs routinely collected at hospital admission. Results: Results revealed a significant prevalence of colonization by multidrug-resistant Gram-negative bacilli and Staphylococcus aureus strains resistant to methicillin (MRSA). Discussion: Early detection of these pathogens is fundamental for adopting effective infection control measures and optimizing antimicrobial therapy. Active surveillance at hospital admission, even in patients without prior hospitalizations, proved essential for containing the spread of these microorganisms in the hospital environment. Conclusion: The findings reinforce the need to expand prevention strategies, including the rational use of antimicrobials, hand hygiene, and the isolation of colonized patients, contributing to patient safety and the reduction of hospital-acquired infection rates.
Downloads
References
ANVISA. Agência Nacional de Vigilância Sanitária. Programa nacional de prevenção e controle de infecções relacionadas à assistência à saúde (PNPCIRAS) 2021-2025. Brasília, DF: Anvisa, 2021.
BARLAM, T. F. et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, Oxford, v. 62, n. 10, p. e51-e77, 2016. DOI: https://doi.org/10.1093/cid/ciw118
BRASIL. Ministério da Saúde. Plano de ação nacional de prevenção e controle da resistência aos antimicrobianos no âmbito da saúde única (PAN-BR) 2018-2022. Brasília, DF: Ministério da Saúde, 2018. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/plano_nacional_resistencia_antimicrobianos.pdf. Acesso em: 20 jul. 2025.
CENTERS FOR DISEASE CONTROL AND PREVENTION. Management of multidrug-resistant organisms in healthcare settings. Atlanta: CDC, 2006. Disponível em: https://www.cdc.gov/infection-control/hcp/mdro-management/. Acesso em: 20 jul. 2025.
DAVIES, J.; DAVIES, D. Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, Washington, v. 74, n. 3, p. 417-433, 2010. DOI: https://doi.org/10.1128/MMBR.00016-10
MAGIORAKOS, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, Oxford, v. 18, n. 3, p. 268-281, 2012. DOI: https://doi.org/10.1111/j.1469-0691.2011.03570.x
MURRAY, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, London, v. 399, n. 10325, p. 629-655, 2022.
O'NEILL, J. Tackling drug-resistant infections globally: final report and recommendations. London: Review on Antimicrobial Resistance, 2016.
RIBEIRO, J. et al. High frequency of colonization and absence of identifiable risk factors for methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units in Brazil.
Brazilian Journal of Infectious Diseases, Salvador, v. 5, n. 1, p. 1-7, 2001.
SALOMÃO, M. C. et al. Increased risk for carbapenem-resistant Enterobacteriaceae colonization in intensive care units after hospitalization in emergency department. Emerging Infectious Diseases, Atlanta, v. 26, n. 6, p. 1156-1163, 2020. DOI: https://doi.org/10.3201/eid2606.190965
SIEGEL, J. D. et al. Management of multidrug-resistant organisms in healthcare settings, 2006. American Journal of Infection Control, St. Louis, v. 35, n. 10, supl. 2, p. S165-S193, 2007. DOI: https://doi.org/10.1016/j.ajic.2007.10.006
VENTOLA, C. L. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics, Mechanicsburg, v. 40, n. 4, p. 277-283, 2015.
WORLD HEALTH ORGANIZATION. Global action plan on antimicrobial resistance. Geneva: WHO, 2015.
WORLD HEALTH ORGANIZATION. WHO guidelines on hand hygiene in health care. Geneva: WHO, 2009.
WORLD HEALTH ORGANIZATION. Global antimicrobial resistance and use surveillance system (GLASS) report 2022. Geneva: WHO, 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista Saber Digital

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Declaração de Direito Autoral
Autores que publicam na Revista Saber Digital concordam com os seguintes termos:
Os autores mantêm os direitos e cedem à revista o direito à primeira publicação, simultaneamente submetido a uma licença Creative Commons que permite o compartilhamento por terceiros com a devida menção ao autor e à primeira publicação pela Revista Saber Digital.
Os autores podem entrar em acordos contratuais adicionais e separados para a distribuição não exclusiva da versão publicada da obra (por exemplo, postá-la em um repositório institucional ou publicá-la em um livro), com o reconhecimento de sua publicação inicial na Revista Saber Digital.

Este obra está licenciado com uma Licença https://creativecommons.org/licenses/by-nc/4.0/











